% | Unadjusted OR (95% CI) | Adjusted OR (95% CI)a | Adjusted p-valuea | |
---|---|---|---|---|
≥1 Hospital episode | 82 | |||
Male vs Female | 87 vs 78 | 1.89 (1.78–2.00) | 1.58 (1.48–1.67) | < 0.0001 |
Age (OR per 5-year increase in age)b | 0.74 (0.72–0.75) | 0.82 (0.81–0.84)* | < 0.0001 | |
70–79 | 88 | 2.77 (2.57–2.99) | 1.83 (1.69–1.99) | |
80–89 | 84 | 2.02 (1.90–2.15) | 1.67 (1.56–1.79) | |
90+ | 72 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Socioeconomic quintile (OR per increase in quintile) | 0.95 (0.93–0.97) | 0.95 (0.92–0.97)* | < 0.0001 | |
Most disadvantaged quintile | 85 | 1.28 (1.17–1.40) | 1.30 (1.17–1.44) | |
Quintile 2 | 83 | 1.09 (1.00–1.19) | 1.07 (0.97–1.18) | |
Quintile 3 | 82 | 1.03 (0.94–1.12) | 1.02 (0.93–1.12) | |
Quintile 4 | 82 | 1.00 (0.92–1.10) | 0.96 (0.87–1.05) | |
Least disadvantaged quintile | 82 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Place of residence: Other vs Major cities | 82 vs 83 | 0.95 (0.90–1.01) | 0.87 (0.82–0.94) | 0.0002 |
Cancer vs Non-cancer death | 95 vs 78 | 5.16 (4.67–5.69) | 4.29 (3.88–4.74) | < 0.0001 |
> 3 hospital episodes | 21 | |||
Male vs Female | 25 vs 17 | 1.66 (1.58–1.75) | 1.38 (1.31–1.46) | < 0.0001 |
Age (OR per 5-year increase in ageb | 0.73 (0.72–0.75) | 0.79 (0.78–0.81)* | < 0.0001 | |
70–79 | 29 | 3.32 (3.06–3.61) | 2.42 (2.22–2.64) | |
80–89 | 20 | 2.07 (1.92–2.25) | 1.77 (1.63–1.92) | |
90+ | 11 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Socioeconomic quintile (OR per increase in quintile) | 1.00 (0.98–1.02) | 1.01 (0.99–1.04)* | 0.24 | |
Most disadvantaged quintile | 22 | 1.01 (0.93–1.10) | 0.96 (0.88–1.06) | |
Quintile 2 | 21 | 0.97 (0.89–1.05) | 0.90 (0.82–0.98) | |
Quintile 3 | 19 | 0.86 (0.79–0.93) | 0.82 (0.75–0.89) | |
Quintile 4 | 21 | 0.96 (0.88–1.05) | 0.91 (0.84–1.00) | |
Least disadvantaged quintile | 22 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Place of residence: Other vs Major cities | 20 vs 21 | 0.95 (0.90–1.00) | 0.95 (0.89–1.02) | 0.16 |
Cancer vs Non-cancer death | 35 vs 16 | 2.78 (2.63–2.94) | 2.33 (2.20–2.47) | < 0.0001 |
Prolonged single hospitalisation (> 30 days) | 21 | |||
Male vs Female | 22 vs 20 | 1.16 (1.10–1.22) | 1.09 (1.03–1.15) | 0.002 |
Age (OR per 5-year increase in age)b | 0.93 (0.91–0.95) | 0.96 (0.94–0.98)* | < 0.0001 | |
70–79 | 22 | 1.34 (1.25–1.45) | 1.18 (1.09–1.28) | |
80–89 | 22 | 1.32 (1.23–1.41) | 1.24 (1.16–1.33) | |
90+ | 17 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Socioeconomic quintile (OR per increase in quintile) | 1.02 (1.00–1.04) | 1.04 (1.02–1.06)* | 0.0003 | |
Most disadvantaged quintile | 20 | 0.91 (0.84–0.99) | 0.85 (0.78–0.94) | |
Quintile 2 | 20 | 0.93 (0.86–1.01) | 0.86 (0.79–0.94) | |
Quintile 3 | 21 | 1.00 (0.92–1.08) | 0.96 (0.88–1.04) | |
Quintile 4 | 20 | 0.93 (0.85–1.02) | 0.91 (0.84–1.00) | |
Least disadvantaged quintile | 22 | 1.00 (reference) | 1.00 (reference) | 0.002 |
Place of residence: Other vs Major cities | 21 vs 20 | 1.06 (1.00–1.12) | 1.11 (1.04–1.18) | 0.002 |
Cancer vs Non-cancer death | 26 vs 19 | 1.51 (1.43–1.60) | 1.45 (1.37–1.54) | < 0.0001 |
> 3 months total hospitalisation | 7 | |||
Male vs Female | 7 vs 6 | 1.11 (1.02–1.21) | 1.02 (0.94–1.11) | 0.64 |
Age (OR per 5-year increase in age)b | 0.86 (0.84–0.89) | 0.87 (0.84–0.89)* | < 0.0001 | |
70–79 | 8 | 1.77 (1.56–2.01) | 1.72 (1.51–1.96) | |
80–89 | 7 | 1.45 (1.29–1.64) | 1.43 (1.27–1.62) | |
90+ | 5 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Socioeconomic quintile (OR per increase in quintile) | 0.93 (0.90–0.95) | 0.99 (0.95–1.02)* | 0.52 | |
Most disadvantaged quintile | 8 | 1.35 (1.17–1.55) | 1.07 (0.92–1.24) | |
Quintile 2 | 7 | 1.23 (1.07–1.41) | 0.98 (0.85–1.14) | |
Quintile 3 | 7 | 1.18 (1.03–1.35) | 1.03 (0.89–1.19) | |
Quintile 4 | 6 | 1.03 (0.88–1.19) | 0.97 (0.84–1.13) | |
Least disadvantaged quintile | 6 | 1.00 (reference) | 1.00 (reference) | 0.67 |
Place of residence: Other vs Major cities | 8 vs 6 | 1.46 (1.34–1.59) | 1.41 (1.28–1.56) | < 0.0001 |
Cancer vs Non-cancer death | 7 vs 6 | 1.16 (1.05–1.27) | 1.05 (0.96–1.16) | 0.29 |
ICU admission | 9 | |||
Male vs Female | 11 vs 8 | 1.57 (1.46–1.68) | 1.29 (1.19–1.39) | < 0.0001 |
Age (OR per 5-year increase in age)b | 0.65 (0.63–0.67) | 0.65 (0.63–0.67)* | < 0.0001 | |
70–79 | 16 | 6.03 (5.24–6.94) | 6.05 (5.24–6.99) | |
80–89 | 9 | 3.10 (2.70–3.57) | 3.06 (2.66–3.53) | |
90+ | 3 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Socioeconomic quintile (OR per increase in quintile) | 0.94 (0.91–0.96) | 0.94 (0.91–0.96)* | < 0.0001 | |
Most disadvantaged quintile | 13 | 1.29 (1.16–1.44) | 1.30 (1.15–1.46) | |
Quintile 2 | 9 | 0.83 (0.74–0.94) | 0.84 (0.74–0.95) | |
Quintile 3 | 8 | 0.81 (0.72–0.90) | 0.80 (0.71–0.90) | |
Quintile 4 | 8 | 0.77 (0.68–0.88) | 0.73 (0.64–0.82) | |
Least disadvantaged quintile | 10 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Place of residence: Other vs Major cities | 8 vs 10 | 0.81 (0.74–0.87) | 0.72 (0.66–0.79) | < 0.0001 |
Cancer vs Non-cancer death | 9 vs 9 | 0.98 (0.90–1.07) | 0.72 (0.66–0.79) | < 0.0001 |
≥1 ED presentationc | 79 | |||
Male vs Female | 83 vs 76 | 1.56 (1.46–1.67) | 1.42 (1.32–1.53) | < 0.0001 |
Age (OR per 5-year increase in ageb | 0.83 (0.81–0.85) | 0.88 (0.86–0.90)* | < 0.0001 | |
70–79 | 84 | 1.94 (1.77–2.12) | 1.55 (1.41–1.71) | |
80–89 | 80 | 1.54 (1.42–1.67) | 1.37 (1.27–1.49) | |
90+ | 73 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Socioeconomic quintile (OR per increase in quintile) | 0.79 (0.77–0.81) | 0.80 (0.78–0.82)* | < 0.0001 | |
Most disadvantaged quintile | 87 | 2.68 (2.38–3.02) | 2.53 (2.25–2.85) | |
Quintile 2 | 84 | 2.02 (1.82–2.24) | 1.91 (1.71–2.12) | |
Quintile 3 | 83 | 1.95 (1.76–2.17) | 1.90 (1.71–2.12) | |
Quintile 4 | 80 | 1.57 (1.44–1.71) | 1.53 (1.40–1.67) | |
Least disadvantaged quintile | 72 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Place of residence: Other vs Major cities | 82 vs 79 | 1.16 (1.00–1.35) | 1.02 (0.88–1.20) | 0.75 |
Cancer vs Non-cancer death | 83 vs 78 | 1.33 (1.23–1.44) | 1.17 (1.07–1.27) | 0.0003 |
> 3 ED presentationsc | 17 | |||
Male vs Female | 20 vs 14 | 1.46 (1.35–1.56) | 1.34 (1.24–1.44) | < 0.0001 |
Age (OR per 5-year increase in age)b | 0.85 (0.83–0.87) | 0.88 (0.86–0.91)* | < 0.0001 | |
70–79 | 20 | 1.91 (1.72–2.13) | 1.63 (1.45–1.82) | |
80–89 | 17 | 1.54 (1.40–1.71) | 1.41 (1.27–1.56) | |
90+ | 12 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Socioeconomic quintile (OR per increase in quintile) | 0.84 (0.82–0.87) | 0.86 (0.84–0.88)* | < 0.0001 | |
Most disadvantaged quintile | 22 | 2.02 (1.80–2.26) | 1.90 (1.69–2.13) | |
Quintile 2 | 21 | 1.90 (1.71–2.13) | 1.77 (1.58–1.98) | |
Quintile 3 | 16 | 1.41 (1.25–1.59) | 1.37 (1.22–1.55) | |
Quintile 4 | 17 | 1.45 (1.31–1.61) | 1.40 (1.26–1.56) | |
Least disadvantaged quintile | 12 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Place of residence: Other vs Major cities | 21 vs 17 | 1.32 (1.14–1.52) | 1.15 (0.99–1.33) | 0.07 |
Cancer vs Non-cancer death | 18 vs 16 | 1.17 (1.08–1.27) | 1.04 (0.96–1.13) | 0.33 |
Palliative care input: broader definitiond,e | 21 | |||
Male vs Female | 24 vs 18 | 1.39 (1.32–1.47) | 1.04 (0.98–1.10) | 0.21 |
Age (OR per 5-year increase in age)b | 0.72 (0.71–0.73) | 0.85 (0.83–0.86)* | < 0.0001 | |
70–79 | 30 | 3.37 (3.11–3.65) | 1.84 (1.68–2.02) | |
80–89 | 19 | 1.86 (1.72–2.01) | 1.37 (1.25–1.49) | |
90+ | 11 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Socioeconomic quintile (OR per increase in quintile) | 1.05 (1.03–1.07) | 1.02 (1.00–1.05)* | 0.05 | |
Most disadvantaged quintile | 22 | 0.93 (0.85–1.01) | 1.05 (0.95–1.16) | |
Quintile 2 | 19 | 0.77 (0.71–0.84) | 0.73 (0.66–0.80) | |
Quintile 3 | 18 | 0.75 (0.69–0.81) | 0.73 (0.66–0.80) | |
Quintile 4 | 24 | 1.03 (0.95–1.12) | 1.01 (0.92–1.11) | |
Least disadvantaged quintile | 23 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Place of residence: Other vs Major cities | 18 vs 22 | 0.74 (0.70–0.78) | 0.73 (0.68–0.79) | < 0.0001 |
Cancer vs Non-cancer death | 54 vs 10 | 11.13 (10.49–11.81) | 10.24 (9.63–10.89) | < 0.0001 |
Death in inpatient setting | 53 | |||
Male vs Female | 59 vs 49 | 1.55 (1.48–1.61) | 1.31 (1.25–1.37) | < 0.0001 |
Age (OR per 5-year increase in age)b | 0.75 (0.74–0.76) | 0.80 (0.79–0.82)* | < 0.0001 | |
70–79 | 64 | 2.83 (2.66–3.00) | 2.17 (2.04–2.31) | |
80–89 | 54 | 1.82 (1.73–1.92) | 1.60 (1.51–1.69) | |
90+ | 39 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Socioeconomic quintile (OR per increase in quintile) | 0.92 (0.90–0.93) | 0.93 (0.92–0.95)* | < 0.0001 | |
Most disadvantaged quintile | 59 | 1.41 (1.31–1.51) | 1.34 (1.24–1.45) | |
Quintile 2 | 56 | 1.25 (1.17–1.34) | 1.17 (1.09–1.26) | |
Quintile 3 | 52 | 1.08 (1.01–1.15) | 1.03 (0.96–1.11) | |
Quintile 4 | 51 | 1.06 (0.99–1.13) | 1.01 (0.94–1.09) | |
Least disadvantaged quintile | 50 | 1.00 (reference) | 1.00 (reference) | < 0.0001 |
Place of residence: Other vs Major cities | 55 vs 53 | 1.08 (1.04–1.13) | 0.99 (0.94–1.04) | 0.62 |
Cancer vs Non-cancer death | 68 vs 48 | 2.31 (2.20–2.44) | 1.96 (1.86–2.06) | < 0.0001 |